LeMaitre Vascular LMAT Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about LeMaitre Vascular's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is LeMaitre Vascular's additional paid-in capital?
- LeMaitre Vascular (LMAT) reported additional paid-in capital of $233.45M in Q1 2026.
- How has LeMaitre Vascular's additional paid-in capital changed year-over-year?
- LeMaitre Vascular's additional paid-in capital increased by 7.5% year-over-year, from $217.12M to $233.45M.
- What is the long-term trend for LeMaitre Vascular's additional paid-in capital?
- Over 5 years (2020 to 2025), LeMaitre Vascular's additional paid-in capital has grown at a 14.7% compound annual growth rate (CAGR), from $114.92M to $228.41M.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.